These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1653186)
61. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure. Buikema H; Monnink SH; Tio RA; Crijns HJ; de Zeeuw D; van Gilst WH Br J Pharmacol; 2000 Aug; 130(8):1999-2007. PubMed ID: 10952693 [TBL] [Abstract][Full Text] [Related]
62. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme. Andújar-Sánchez M; Cámara-Artigas A; Jara-Pérez V Biophys Chem; 2004 Oct; 111(2):183-9. PubMed ID: 15381315 [TBL] [Abstract][Full Text] [Related]
63. Effects of captopril and enalaprilat on intracellular Ca2+ content in isolated cardiomyocytes from rats. Wang J; Zhang L; Qi JH; Zhang PJ; Wei PJ; Gu PK; Jin ZJ Zhongguo Yao Li Xue Bao; 1996 May; 17(3):233-5. PubMed ID: 9812744 [TBL] [Abstract][Full Text] [Related]
64. Angiotensin converting enzyme inhibitors, captopril and enalaprilat, augment bradykinin-induced prostacyclin synthesis in cultured rat vascular smooth muscle cells. Takeuchi K; Abe K; Sato M; Yasujima M; Omata K; Kasai Y; Kanazawa M; Fang SN; Yoshinaga K Adv Exp Med Biol; 1989; 247B():489-94. PubMed ID: 2558520 [No Abstract] [Full Text] [Related]
65. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Ibrahim MA; Ashour OM; Ibrahim YF; El-Bitar HI; Gomaa W; Abdel-Rahim SR Pharmacol Res; 2009 Nov; 60(5):373-81. PubMed ID: 19467331 [TBL] [Abstract][Full Text] [Related]
66. Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies. Borghi C; Omboni S; Reggiardo G; Bacchelli S; Esposti DD; Ambrosioni E; BMC Cardiovasc Disord; 2018 Jun; 18(1):112. PubMed ID: 29866077 [TBL] [Abstract][Full Text] [Related]
67. Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury. Suzuki H; Matsumori A; Matoba Y; Kyu BS; Tanaka A; Fujita J; Sasayama S J Clin Invest; 1993 Jun; 91(6):2727-33. PubMed ID: 8390488 [TBL] [Abstract][Full Text] [Related]
68. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review. Kubo SH; Cody RJ Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938 [TBL] [Abstract][Full Text] [Related]
70. Effects of captopril and enalaprilat on intracellular Ca2+, Na+ contents and pH in hypoxic and reoxygenated cardiomyocytes. Wang J; Zhang PJ; Zhang L; Qi JH; Wei PJ; Jin ZJ Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):140-2. PubMed ID: 10072966 [TBL] [Abstract][Full Text] [Related]
71. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876 [TBL] [Abstract][Full Text] [Related]
72. Effect of acute and chronic zofenopril administration on cardiac gene expression. Carnicelli V; Frascarelli S; Zucchi R Mol Cell Biochem; 2011 Jun; 352(1-2):301-7. PubMed ID: 21394524 [TBL] [Abstract][Full Text] [Related]
73. The nerve-heart connection in the pro-oxidant response to Mg-deficiency. Tejero-Taldo MI; Kramer JH; Mak IuT; Komarov AM; Weglicki WB Heart Fail Rev; 2006 Mar; 11(1):35-44. PubMed ID: 16819576 [TBL] [Abstract][Full Text] [Related]